Symmetry Partners
DXCM icon

Symmetry Partners’s DexCom DXCM Stock Holding History

Symmetry Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.33M Buy
+15,400
New +$1.28M 0.07% 73
2026
Q2 		– Sell
-15,737
Closed -$988K – 301
2026
Q1 		$988K Buy
15,737
+173
+1% +$12K 0.06% 74
2025
Q4 		$1.03M Buy
15,564
+327
+2% +$21.1K 0.06% 69
2025
Q3 		$1.03M Buy
15,237
+13
+0.1% +$1.03K 0.11% 64
2025
Q2 		$1.33M Buy
15,224
+453
+3% +$35.5K 0.16% 55
2025
Q1 		$1.01M Buy
14,771
+21
+0.1% +$1.71K 0.14% 61
2024
Q4 		$1.15M Sell
14,750
-14
-0.1% -$1.04K 0.16% 57
2024
Q3 		$990K Buy
+14,764
New +$1.21M 0.23% 47
2024
Q2 		– Sell
-1,454
Closed -$202K – 523
2024
Q1 		$202K Buy
+1,454
New +$183K 0.02% 530
2023
Q3 		– Sell
-1,882
Closed -$242K – 539
2023
Q2 		$242K Hold
1,882
– – 0.01% 512
2023
Q1 		$219K Hold
1,882
– – 0.01% 519
2022
Q4 		$213K Buy
+1,882
New +$207K 0.01% 524
2022
Q3 		– Sell
-3,536
Closed -$264K – 553
2022
Q2 		$264K Hold
3,536
– – 0.02% 485
2022
Q1 		$452K Hold
3,536
– – 0.03% 384
2021
Q4 		$475K Hold
3,536
– – 0.03% 408
2021
Q3 		$478K Hold
3,536
– – 0.03% 423
2021
Q2 		$377K Buy
3,536
+680
+24% +$65.3K 0.03% 524
2021
Q1 		$257K Sell
2,856
-1,544
-35% -$145K 0.02% 589
2020
Q4 		$407K Sell
4,400
-532
-11% -$47.5K 0.03% 439
2020
Q3 		$508K Buy
4,932
+2,080
+73% +$217K 0.04% 315
2020
Q2 		$289K Buy
+2,852
New +$255K 0.04% 239
2019
Q2 		– Sell
-11,836
Closed -$352K – 354
2019
Q1 		$352K Buy
11,836
+8,320
+237% +$292K 0.06% 214
2018
Q4 		$105K Buy
+3,516
New +$112K 0.03% 328

Other funds holding DXCM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Symmetry Partners's DXCM Position: Q3 2026 in Review

Symmetry Partners opened a new position in DexCom (DXCM) in Q3 2026: 15,400 shares worth $1.33M. The stake represents 0.07% of the portfolio and ranks #73 among its holdings. This is a return to the name: Symmetry Partners previously reported a position in DXCM as recently as Q1 2026.

Symmetry Partners first reported a position in DXCM in Q4 2018 and has held it in 23 quarters since. The position peaked at $1.33M in Q2 2025. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Symmetry Partners held 15,400 shares of DexCom worth $1.33M as of Q3 2026.
  • DexCom was a new Symmetry Partners position in Q3 2026.
  • DexCom made up 0.07% of Symmetry Partners's portfolio in Q3 2026, its #73 holding.
  • Symmetry Partners first reported a position in DexCom in Q4 2018 and has held it in 23 quarters since.
  • Symmetry Partners's DexCom position peaked at $1.33M in Q2 2025.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Symmetry Partners's 13F filing for Q3 2026, filed 27 Oct 2026.